C Glanzmann
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
-
- Medical Imaging Techniques and Applications
Papers in
-
- Head and Neck Cancer Studies 10
-
- Thyroid Cancer Diagnosis and Treatment 6
- Co-authors
- Klaus W. Grätz (1 shared paper)Martin N. Pruschy (7 shared papers)Stephan B. Bodis (7 shared papers)Urs Martin Lütolf (7 shared papers)Gabriela Studer (5 shared papers)Katrin D. M. Stumpe (1 shared paper)Andreas Konrad Buck (1 shared paper)Hans C. Steinert (1 shared paper)
- Journals
- Radiotherapy and Oncology (4 papers)British Journal of Cancer (3 papers)Strahlentherapie und Onkologie (2 papers)Journal of Molecular Medicine (2 papers)Acta Oncologica (1 paper)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
C Glanzmann
41 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Otorhinolaryngology 244
- Radiology, Nuclear Medicine and Imaging 237
- Pathology and Forensic Medicine 185
- Pulmonary and Respiratory Medicine 317
- Genetics 102
Countries citing papers authored by C Glanzmann
This map shows the geographic impact of C Glanzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Glanzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Glanzmann more than expected).
Fields of papers citing papers by C Glanzmann
This network shows the impact of papers produced by C Glanzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Glanzmann. The network helps show where C Glanzmann may publish in the future.
Co-authors
The 25 scholars most cited alongside C Glanzmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 226 | |
| 2 | 1995 | 140 | |
| 3 | 2001 | 140 | |
| 4 | 2006 | 95 | |
| 5 | 1994 | 91 | |
| 6 | 2006 | 70 | |
| 7 | The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. | 2001 | 64 |
| 8 | 2003 | 53 | |
| 9 | Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412. | 2001 | 46 |
| 10 | Considerations in the radiation treatment of intracranial ependymoma. Prognosis in 24 own cases and results in published series after different techniques of radiation treatment. | 1980 | 32 |
| 11 | Protein kinase C inhibitor and irradiation-induced apoptosis: relevance of the cytochrome c-mediated caspase-9 death pathway. | 2000 | 32 |
| 12 | Acute toxicity of curative radiotherapy in elderly patients. | 1996 | 27 |
| 13 | E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53. | 1999 | 25 |
| 14 | 1999 | 25 | |
| 15 | Subsequent malignancies in patients treated with 131-iodine for thyroid cancer. | 1992 | 22 |
| 16 | Radiotherapy for carcinomas of the head and neck in elderly patients. | 1996 | 22 |
| 17 | 1989 | 20 | |
| 18 | The risk of chronic progressive radiation myelopathy. | 1976 | 15 |
| 19 | 2013 | 15 | |
| 20 | Incidence of second solid cancer in patients after treatment of Hodgkin's disease. | 1994 | 14 |
About C Glanzmann
C Glanzmann is a scholar working on Otorhinolaryngology, Endocrinology, Diabetes and Metabolism, Genetics, Oncology and Neurology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (10 papers), Glioma Diagnosis and Treatment (6 papers), Thyroid Cancer Diagnosis and Treatment (6 papers), Management of metastatic bone disease (3 papers), Cell death mechanisms and regulation (3 papers), Neuroblastoma Research and Treatments (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Otorhinolaryngology (244 citations), Radiology, Nuclear Medicine and Imaging (237 citations), Pathology and Forensic Medicine (185 citations), Pulmonary and Respiratory Medicine (317 citations) and Genetics (102 citations). C Glanzmann has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Klaus W. Grätz, Martin N. Pruschy, Stephan B. Bodis, Urs Martin Lütolf, Gabriela Studer, Katrin D. M. Stumpe, Andreas Konrad Buck, Hans C. Steinert, Gustav Konrad von Schulthess and P Huguenin. Their work appears in journals such as Radiotherapy and Oncology, British Journal of Cancer, Strahlentherapie und Onkologie, Journal of Molecular Medicine and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.